linagliptin and semaglutide Is it safe to combine (a DPP‑4 inhibitor) with (a GLP‑1 receptor agonist) in a patient with type 2 diabetes who is already taking empagliflozin (an SGLT2 inhibitor)? Full article: Medication Adherence to

Aspirin works to treat heart attacks because it inhibits platelets, a type of blood cell that causes blood clots to form

Absolute Pharmacy carries a lengthy regulatory record, including an FDA Warning Letter, outsourcing-facility de-registration, and state license revocations

A subanalysis of the SELECT trial on obesity related cancer incidence would be fascinating

GLP-1 medicationsincluding semaglutide, liraglutide, and dulaglutidework by mimicking a natural hormone that regulates blood glucose and appetite

Glycaemic control remains paramountpatients with diabetes should monitor blood glucose levels regularly and work with their healthcare team to optimise diabetic management alongside Wegovy treatment